|
Home
|
E-Submission
|
Sitemap
|
Contact Us
|
HOME
ABOUT
Aims and Scope
About the Journal
About the Society
Editorial Board
Managing Team
Best Practice
Metrics
JMD Introduction Video
Contact us
BROWSE ARTICLES
Journal Archive
Early View
Current Issue
Most Cited Articles
J Mov Disord
Search
Author Index
CURRENT ISSUE
FOR CONTRIBUTIONS
For Authors
Instructions for Authors
Ethical Policy
Author's Checklist
Copyright Transfer Agreement
Article Processing Charge
E-Submission
For Reviewers
Instructions for Reviewers
How to Become a Reviewer?
FOR READERS
Readership
Open Access
Subscription
TOC Alerts
Journal of Movement Disorders
Search
> Browse Articles > Search
Current Status of Telemedicine for
Parkinson’s Disease
in Japan: A Single-Center Cross-Sectional Questionnaire Survey
Mayuko Ogawa, Genko Oyama, Satoko Sekimoto, Taku Hatano, Nobutaka Hattori
J Mov Disord.
2022;15(1):58-61. Published online December 24, 2021 DOI:
https://doi.org/10.14802/jmd.21096
Dance Intervention Using the Feldenkrais Method Improves Motor, and Non-Motor Symptoms and Gait in
Parkinson’s Disease
: A 12-Month Study
Sung Hoon Kang, Jinhee Kim, Ilsoo Kim, Young Ae Moon, Sojung Park, Seong-Beom Koh
J Mov Disord.
2022;15(1):53-57. Published online November 3, 2021 DOI:
https://doi.org/10.14802/jmd.21086
Constipation is Associated With Mild Cognitive Impairment in Patients With de novo
Parkinson’s Disease
Sung Hoon Kang, Jungyeun Lee, Seong-Beom Koh
J Mov Disord.
2022;15(1):38-42. Published online November 17, 2021 DOI:
https://doi.org/10.14802/jmd.21074
Association of
AXIN1
With
Parkinson’s Disease
in a Taiwanese Population
Hwa-Shin Fang, Chih-Ying Chao, Chun-Chieh Wang, Wen-Lang Fan, Po-Jung Huang, Hon-Chung Fung, Yih-Ru Wu
J Mov Disord.
2022;15(1):33-37. Published online November 17, 2021 DOI:
https://doi.org/10.14802/jmd.21073
The Supplementary Motor Complex in
Parkinson’s Disease
Shervin Rahimpour, Shashank Rajkumar, Mark Hallett
J Mov Disord.
2022;15(1):21-32. Published online November 25, 2021 DOI:
https://doi.org/10.14802/jmd.21075
Evidence of Inflammation in
Parkinson’s Disease
and Its Contribution to Synucleinopathy
Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim
J Mov Disord.
2022;15(1):1-14. Published online November 3, 2021 DOI:
https://doi.org/10.14802/jmd.21078
Cited By 1
Focused Vibrotactile Stimulation with Cueing Effect on Freezing of Gait in
Parkinson’s Disease
: Two Case Reports
Xiu Sheng Tan, Floyd Pierres, Alex Dallman-Porter, William Hardie-Brown, Kyum-Yil Kwon
J Mov Disord.
2021;14(3):236-238. Published online September 8, 2021 DOI:
https://doi.org/10.14802/jmd.21076
Cited By 2
Investigation of Nocturnal Hypokinesia and Health-Related Quality of Life in Parkinsonian Patients with the Korean Version of the Nocturnal Hypokinesia Questionnaire
Ji-Hyun Choi, Jee-Young Lee, Chaewon Shin, Dallah Yoo, Jin Hee Im, Kyung Ah Woo, Han-Joon Kim, Tae-Beom Ahn, Jong-Min Kim, Beomseok Jeon
J Mov Disord.
2021;14(3):221-225. Published online May 26, 2021 DOI:
https://doi.org/10.14802/jmd.20172
Increased Mortality in Young-Onset
Parkinson’s Disease
Eldbjørg Hustad, Tor Åge Myklebust, Sasha Gulati, Jan O. Aasly
J Mov Disord.
2021;14(3):214-220. Published online July 29, 2021 DOI:
https://doi.org/10.14802/jmd.21029
Cited By 1
The Four Square Step Test for Assessing Cognitively Demanding Dynamic Balance in
Parkinson’s Disease
Patients
Jinhee Kim, Ilsoo Kim, Ye Eun Kim, Seong-Beom Koh
J Mov Disord.
2021;14(3):208-213. Published online May 26, 2021 DOI:
https://doi.org/10.14802/jmd.20146
Emerging Nondopaminergic Medications for
Parkinson’s Disease
: Focusing on A
2A
Receptor Antagonists and GLP1 Receptor Agonists
Pei Shang, Matthew Baker, Samantha Banks, Sa-Ik Hong, Doo-Sup Choi
J Mov Disord.
2021;14(3):193-203. Published online August 18, 2021 DOI:
https://doi.org/10.14802/jmd.21035
Cited By 3
Parkinson’s Disease
and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
Smriti Sinha, Swati Mittal, Rupali Roy
J Mov Disord.
2021;14(3):184-192. Published online July 29, 2021 DOI:
https://doi.org/10.14802/jmd.21046
Cited By 2
Management of
Parkinson’s Disease
in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination
Yue Hui Lau, Keng Ming Lau, Norlinah Mohamed Ibrahim
J Mov Disord.
2021;14(3):177-183. Published online July 29, 2021 DOI:
https://doi.org/10.14802/jmd.21034
Cited By 1
Factors Associated with Medication Beliefs in Patients with
Parkinson’s Disease
: A Cross-Sectional Study
Sung Reul Kim, Ji Young Kim, Hye Young Kim, Hui Young So, Sun Ju Chung
J Mov Disord.
2021;14(2):133-143. Published online May 3, 2021 DOI:
https://doi.org/10.14802/jmd.20147
Cited By 1
Knowledge, Attitude, and Perceptions about Deep Brain Stimulation for
Parkinson’s Disease
: Observations from a Single Indian Center
Shweta Prasad, Amitabh Bhattacharya, Lulup Kumar Sahoo, Dhruv Batra, Nitish Kamble, Ravi Yadav, Dwarakanath Srinivas, Pramod Kumar Pal
J Mov Disord.
2021;14(1):60-64. Published online September 21, 2020 DOI:
https://doi.org/10.14802/jmd.20066
Cited By 2
Health-Related Quality of Life for
Parkinson’s Disease
Patients and Their Caregivers
Michal Lubomski, Ryan L. Davis, Carolyn M. Sue
J Mov Disord.
2021;14(1):42-52. Published online January 12, 2021 DOI:
https://doi.org/10.14802/jmd.20079
Cited By 11
The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from
Parkinson’s Disease
Peter Cornelis Poortvliet, Alexander Gluch, Peter A. Silburn, George D. Mellick
J Mov Disord.
2021;14(1):34-41. Published online December 7, 2020 DOI:
https://doi.org/10.14802/jmd.20034
Cited By 5
Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria
Yoshio Tsuboi, Takayasu Mishima, Shinsuke Fujioka
J Mov Disord.
2021;14(1):1-9. Published online September 21, 2020 DOI:
https://doi.org/10.14802/jmd.20060
Cited By 4
Young-Onset
Parkinson’s Disease
with Impulse Control Disorder Due to Novel Variants of F-Box Only Protein 7
Dallah Yoo, Ji-Hyun Choi, Jin-Hee Im, Man Jin Kim, Han-Joon Kim, Sung Sup Park, Beomseok Jeon
J Mov Disord.
2020;13(3):225-228. Published online September 9, 2020 DOI:
https://doi.org/10.14802/jmd.20026
Effectiveness of Exercise on the Sequence Effect in
Parkinson’s Disease
Suk Yun Kang, Young Ho Sohn
J Mov Disord.
2020;13(3):213-217. Published online August 31, 2020 DOI:
https://doi.org/10.14802/jmd.20045
Cited By 1
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with
Parkinson’s Disease
Kye Won Park, Sungyang Jo, Seung Hyun Lee, Yun Su Hwang, Dagyo Lee, Ho-Sung Ryu, Sun Ju Chung
J Mov Disord.
2020;13(3):205-212. Published online September 9, 2020 DOI:
https://doi.org/10.14802/jmd.20055
Cited By 2
Parkinson Anxiety Scale: A Validation Study for the Brazilian Population
Renilson Moraes-Ferreira, Wilson Mateus Gomes da Costa Alves, Maysa Alves Rodrigues Brandao-Rangel, Odilon Abrahin, Clebson Pantoja Pimentel, Evitom Correa-Sousa, Rodolfo Paula Vieira, Erik Artur Cortinhas-Alves
J Mov Disord.
2020;13(3):199-204. Published online July 28, 2020 DOI:
https://doi.org/10.14802/jmd.20031
Emerging Concepts of Motor Reserve in
Parkinson’s Disease
Seok Jong Chung, Jae Jung Lee, Phil Hyu Lee, Young H. Sohn
J Mov Disord.
2020;13(3):171-184. Published online August 31, 2020 DOI:
https://doi.org/10.14802/jmd.20029
Cited By 8
Treatment of Acute Delirium in a Patient with
Parkinson’s Disease
by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine
Morgan Lombardo, Amanda DiPiazza, Kelly Rippey, Naomi Lubarr, Elana Clar, Hooman Azmi
J Mov Disord.
2020;13(2):159-162. Published online May 29, 2020 DOI:
https://doi.org/10.14802/jmd.20005
Cited By 1
Sedentary Time is Associated with Worse Attention in
Parkinson’s Disease
: A Pilot Study
Sara B. W. Troutman, Kirk I. Erickson, George Grove, Andrea M. Weinstein
J Mov Disord.
2020;13(2):146-149. Published online May 29, 2020 DOI:
https://doi.org/10.14802/jmd.20015
Risk Factors for Falls in Patients with de novo
Parkinson’s Disease
: A Focus on Motor and Non-Motor Symptoms
Kyum-Yil Kwon, Mina Lee, Hyunjin Ju, Kayeong Im
J Mov Disord.
2020;13(2):142-145. Published online May 29, 2020 DOI:
https://doi.org/10.14802/jmd.20009
Cited By 3
COVID-19: An Early Review of Its Global Impact and Considerations for
Parkinson’s Disease
Patient Care
Roongroj Bhidayasiri, Sasivimol Virameteekul, Jong-Min Kim, Pramod Kr. Pal, Sun-Ju Chung
J Mov Disord.
2020;13(2):105-114. Published online April 30, 2020 DOI:
https://doi.org/10.14802/jmd.20042
Cited By 39
Long-Term Outcomes of Genetic
Parkinson’s Disease
Jan O. Aasly
J Mov Disord.
2020;13(2):81-96. Published online May 29, 2020 DOI:
https://doi.org/10.14802/jmd.19080
Cited By 5
Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
Juan Miguel Pilar Bautista, Genko Oyama, Maierdanjiang Nuermaimaiti, Satoko Sekimoto, Fuyuko Sasaki, Taku Hatano, Kenya Nishioka, Masanobu Ito, Atsushi Umemura, Yuji Ishibashi, Yasushi Shimo, Nobutaka Hattori
J Mov Disord.
2020;13(1):57-61. Published online January 31, 2020 DOI:
https://doi.org/10.14802/jmd.19051
Cited By 5
Comparison of Spontaneous Motor Tempo during Finger Tapping, Toe Tapping and Stepping on the Spot in People with and without
Parkinson’s Disease
Dawn Rose, Daniel J. Cameron, Peter J. Lovatt, Jessica A. Grahn, Lucy E. Annett
J Mov Disord.
2020;13(1):47-56. Published online January 31, 2020 DOI:
https://doi.org/10.14802/jmd.19043
Cited By 6
1
|
2
|
3
|
4
|